Sarah Bennett
Antibodies, also known as immunoglobulins, are glycoproteins produced by B cells that play a crucial role in the immune system's defence against pathogens. They recognise and bind to specific molecules called antigens, which are unique to pathogens. This binding process is essential for neutralising pathogens by blocking their ability to attach to host cells and infect them. The antibodies attach to pathogen ligands or antigens on the pathogen's surface, hindering their ability to bind to host cell receptors. This mechanism is observed in various pathogens, including viruses, bacteria, and parasites. The specificity of antibodies ensures that they recognise and bind to the correct antigens, contributing to the immune system's ability to distinguish between different pathogens and generate an appropriate response.
| Characteristics | Values |
|---|---|
| What antibodies attach to | Antigens on the pathogen |
| Where antibodies are distributed | Epithelial surfaces like the gut, respiratory epithelium, urogenital tract, lactating breast, etc. |
| Antibody function | Prevent attachment of pathogens to epithelial cells, protect against toxins, and provide the first line of defense against pathogens |
| Antibody specificity | Antibodies are monospecific if they have specificity for a single antigen or epitope |
| Antibody binding | Antibodies bind to unique molecules of a pathogen, called antigens |
| Antibody affinity | Refers to how strongly a single antibody binds to a given antigen |
| Antibody avidity | Refers to the binding of a multimeric antibody to multiple antigens |
| Antibody cross-reactivity | When an antibody binds to a different but similar antigen than the one for which it was raised |
| Antibody types | Natural antibodies, monoclonal antibodies, heterodimeric antibodies |
Explore related products
What You'll Learn
Antibodies attach to pathogen antigens
Antibodies, also known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by B-cells as a primary immune defence. Antibodies specifically bind to unique molecules of a pathogen, called antigens. Each antibody recognises one specific antigen, and each B cell produces one kind of antibody. This is called "antibody specificity".
Antibodies can bind to antigens on the surface of bacteria, for example, attracting the first component of the complement cascade with their Fc region and initiating the activation of the "classical" complement system. This results in the killing of bacteria in two ways. Firstly, the binding of the antibody and complement molecules marks the microbe for ingestion by phagocytes in a process called opsonization. Secondly, some complement system components form a membrane attack complex to assist antibodies in killing the bacterium directly. Antibodies can also induce the innate immune response to destroy a pathogen by activating phagocytes such as macrophages or neutrophils, which are attracted to antibody-bound cells.
Antibodies can also prevent pathogens from entering or damaging cells by binding to them. They can block key sites on the pathogen that enhance their infectivity, such as receptors that "dock" pathogens on host cells. Antibodies that bind to pathogen ligands essential for the attachment of the pathogen to its host receptor have been described for many pathogens. In the case of viruses, such antibodies generally inhibit infectivity without altering their cognate antigen, thus strictly inhibiting by virtue of steric interference. Antibodies can also prevent the attachment of bacteria or toxins to epithelial cells and the absorption of foreign substances, providing the first line of defence against a wide variety of pathogens.
Antibodies can also mark pathogens for destruction by phagocytic cells, such as macrophages or neutrophils, as they are highly attracted to macromolecules complexed with antibodies. Phagocytic enhancement by antibodies is called opsonization. Antibodies can also link pathogens together, causing them to agglutinate.
AI-Powered mRNA Vaccines: Immune Response Stoppers
You may want to see also
Explore related products
Antibodies block pathogen attachment to host cells
Antibodies, or immunoglobulins (Ig), are large, Y-shaped proteins produced by B cells as a primary immune defence. They are distributed by diffusion from their site of synthesis, but specialised transport mechanisms are required to deliver antibodies to epithelial surfaces, such as the lung and intestine. Antibodies recognise and bind to antigens, which are unique molecules on the surface of pathogens.
Antibodies can block pathogen attachment to host cells in several ways. Firstly, antibodies can bind to pathogen ligands, which are essential for the attachment of the pathogen to its host receptor. This mechanism has been observed in antibodies against HIV-1 gp120, which interfere with the binding of gp120 to CD4. Antibodies can also bind directly to the attachment site of the pathogen, as seen with antibodies against the human rhinovirus, which sterically hinder interactions with its host receptor.
In addition, antibodies can prevent pathogen attachment by inhibiting the infectivity of the pathogen. For example, IgA antibodies prevent the attachment of bacteria or toxins to epithelial cells, providing a defence against a wide range of pathogens. Antibodies can also cause pathogens to aggregate, reducing the number of encounters between the pathogen and host cells, and decreasing infectivity.
Furthermore, antibodies can activate the innate immune response, inducing phagocytes such as macrophages and neutrophils to destroy the pathogen. This process, known as opsonization, marks the pathogen for ingestion and destruction by phagocytic cells. Antibodies can also activate the classical complement pathway, leading to the lysis of virus particles.
Overall, antibodies play a crucial role in blocking pathogen attachment to host cells by recognising and binding to specific antigens, interfering with attachment sites, inhibiting infectivity, and activating the immune response to destroy the pathogen.
The Race for an RSV Vaccine: Is It Possible?
You may want to see also
Explore related products
Antibodies bind to pathogen ligands
Antibodies, also known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by B-cells as a primary immune defence. They are distributed by diffusion from their site of synthesis, but specialised transport mechanisms are required to deliver antibodies to lumenal epithelial surfaces, such as those in the lung and intestine. Antibodies play a crucial role in protecting the body from foreign agents and infectious organisms, including viruses, bacteria, parasites, and fungi.
Antibodies specifically recognise and bind to unique molecules of a pathogen, called antigens. This binding can inhibit pathogen infectivity by blocking key sites on the pathogen, such as receptors that enable them to attach to host cells. Antibodies can also induce the innate immune response to destroy pathogens by activating phagocytes, such as macrophages or neutrophils, which are attracted to antibody-bound cells.
Antibodies that bind to pathogen ligands essential for the attachment of the pathogen to its host receptor have been described for many pathogens. For example, antibodies against HIV-1 gp120 interfere with the binding of gp120 to CD4, inhibiting infectivity without altering the cognate antigen. Similarly, antibodies that neutralise flaviviruses, Newcastle disease virus, papillomavirus, and rotavirus may do so by interfering with attachment.
The binding of antibodies to surface antigens on pathogens, such as bacteria, initiates the activation of the "classical" complement system, resulting in the killing of the pathogen. This process, known as opsonization, involves the attraction of phagocytic cells by complement molecules generated in the complement cascade. Antibodies can also mark pathogens for destruction by phagocytic cells, such as macrophages or neutrophils, through a process called complement fixation, where IgM and IgG in serum bind to antigens, providing docking sites for sequential complement proteins.
Overall, antibodies play a critical role in defending the body against pathogens by binding to pathogen ligands, inhibiting their attachment to host cells, and activating various immune mechanisms to destroy the invading microbes.
How Antibody Production Can Be Stimulated
You may want to see also
Explore related products
Antibodies induce the innate immune response
Antibodies play a crucial role in the immune system's defence against pathogens and other foreign substances. They are produced by B cells, which differentiate into plasma cells to release antibodies into the bloodstream. Each antibody is specific to a particular antigen, recognising and binding to it with precision. This specificity ensures that antibodies only attach to matching antigens, acting as a lock and key mechanism.
The process of antibody attachment to antigens is integral to inducing the innate immune response. Antibodies can directly attach to the cell surface of pathogens, including viruses and bacteria, neutralising them by inhibiting their ability to bind to host receptors. This mechanism of steric interference prevents the attachment of pathogens to epithelial cells and protects the body from infection.
Additionally, antibodies can induce the innate immune response by activating the complement system. The complement system is a biochemical cascade that identifies and opsonises (coats) bacteria and other pathogens, marking them for destruction by phagocytes, a type of innate immune cell. This process, known as phagocytosis, directly kills pathogens and removes foreign substances from the body.
The innate immune system acts as the body's first line of defence, responding rapidly to aggression. It works in synergy with the adaptive immune system, which is antigen-specific and possesses immunological memory. While the innate immune system reacts non-specifically to all foreign substances, it plays a critical role in initiating the immune response and supporting the adaptive immune system's functions.
The antibodies of the adaptive immune system also assist the innate immune system in its duties. They achieve this by recognising and neutralising pathogens, preventing their attachment to host cells, and activating the complement system for pathogen destruction. This coordination between the innate and adaptive immune systems ensures a robust defence against pathogens and maintains the body's overall health.
Blue Cross Blue Shield Illinois: Understanding Your Vaccine Coverage
You may want to see also
Explore related products
Antibodies mark pathogens for destruction
Antibodies, also known as immunoglobulins (Ig), are large, Y-shaped molecules produced by B cells as a primary immune defence. Antibodies specifically bind to unique molecules of a pathogen, called antigens. Each antibody recognises one specific antigen.
Antibodies can block viral infection of cells by inhibiting infectivity or pathogenesis. This neutralisation occurs by interfering with an organism's attachment to host tissues. Antibodies bind to pathogen ligands, essential for the attachment of the pathogen to its host receptor. For example, antibodies against HIV-1 gp120 interfere with the binding of gp120 to CD4. Antibodies can also prevent the attachment of bacteria to epithelial cells.
Antibodies can also induce the innate immune response to destroy a pathogen. They do this by activating phagocytes, such as macrophages or neutrophils, which are attracted to antibody-bound cells. This process is called opsonization. Antibodies can also stimulate effector functions against the pathogen in cells that recognise their Fc region. This results in the destruction of the invading microbe.
Antibodies can also mark pathogens for destruction in another process called complement fixation. IgM and IgG in serum bind to antigens, providing docking sites for sequential complement proteins. The combination of antibodies and complement enhances opsonization, promoting the rapid clearing of pathogens.
Actively Acquired Specific Immunity: Understanding the Options
You may want to see also
Frequently asked questions
Antibodies, also known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by B-cells as a primary immune defence.
Antibodies attach to specific antigens on pathogens.
Antigens are unique molecules found on the surface of pathogens.
When an antibody attaches to an antigen, it marks the pathogen for destruction by phagocytic cells such as macrophages or neutrophils. This process is called opsonization. Antibodies can also induce the innate immune response to destroy a pathogen by activating phagocytes, which are attracted to antibody-bound cells.
Yes, antibodies can prevent infection by blocking key sites on the pathogen that enhance their infectivity, such as receptors that "dock" pathogens on host cells.
